Literature DB >> 23676157

Epidemiology and control of tuberculosis in Victoria, a low-burden state in south-eastern Australia, 2005-2010.

C J Lavender1, M Globan, H Kelly, L K Brown, A Sievers, J A M Fyfe, T Lauer, D E Leslie.   

Abstract

SETTING: Victoria, Australia.
OBJECTIVE: To describe the epidemiology and control of tuberculosis (TB) in Victoria, 2005-2010.
DESIGN: Retrospective review of laboratory-confirmed TB in Victoria, 2005-2010. State TB reference laboratory records were matched with Department of Health notification records to obtain laboratory, demographic, clinical and treatment data.
RESULTS: The incidence of TB fell in the Australian-born population but increased overall, reflecting an increase in the proportion of overseas-born cases from 88.9% to 95.8% between 2005 and 2010 (P = 0.03). Patients from India and Viet Nam accounted for over one third of all cases. For overseas-born cases, the median time between arrival and diagnosis was 4 years. Half of all diagnoses were pulmonary disease, of which 45.4% were Ziehl-Neelsen smear-positive. Treatment was most commonly self-administered (76.9%), and very few patients defaulted or failed treatment (1.1%). Only 4.1% of cases were linked to another laboratory-confirmed case. Multidrug-resistant TB remained uncommon (1.7% of cases).
CONCLUSIONS: TB in Victoria remains low by global standards and continues to overwhelmingly affect the overseas-born population. Current TB control strategies in Victoria are effective, but strengthened control in high-burden countries will also improve TB control locally.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23676157     DOI: 10.5588/ijtld.12.0791

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  6 in total

1.  Mycobacterium orygis Lymphadenitis in New York, USA.

Authors:  Luis A Marcos; Eric D Spitzer; Rahul Mahapatra; Yupo Ma; Tanya A Halse; Joseph Shea; Michelle Isabelle; Pascal Lapierre; Vincent E Escuyer
Journal:  Emerg Infect Dis       Date:  2017-10       Impact factor: 6.883

2.  Reconsidering Mycobacterium bovis as a proxy for zoonotic tuberculosis: a molecular epidemiological surveillance study.

Authors:  Shannon C Duffy; Sreenidhi Srinivasan; Megan A Schilling; Tod Stuber; Sarah N Danchuk; Joy S Michael; Manigandan Venkatesan; Nitish Bansal; Sushila Maan; Naresh Jindal; Deepika Chaudhary; Premanshu Dandapat; Robab Katani; Shubhada Chothe; Maroudam Veerasami; Suelee Robbe-Austerman; Nicholas Juleff; Vivek Kapur; Marcel A Behr
Journal:  Lancet Microbe       Date:  2020-06

3.  A New Phylogenetic Framework for the Animal-Adapted Mycobacterium tuberculosis Complex.

Authors:  Daniela Brites; Chloé Loiseau; Fabrizio Menardo; Sonia Borrell; Maria Beatrice Boniotti; Robin Warren; Anzaan Dippenaar; Sven David Charles Parsons; Christian Beisel; Marcel A Behr; Janet A Fyfe; Mireia Coscolla; Sebastien Gagneux
Journal:  Front Microbiol       Date:  2018-11-27       Impact factor: 5.640

4.  Trends in Tuberculosis Incidence in the Australian-Born in Victoria: Opportunities and Challenges to Elimination.

Authors:  Ouli Xie; Ee Laine Tay; Justin Denholm
Journal:  Trop Med Infect Dis       Date:  2018-10-11

5.  Design, Synthesis and Antitubercular Evaluation of Novel Series of Pyrazinecarboxamide Metal Complexes.

Authors:  Mohsin Ali; Mansoor Ahmed; Saleem Hafiz; Mustafa Kamal; Majid Mumtaz; Seyed Abdulmajid Ayatollahi
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

6.  Tuberculosis in migrants to Australia: Outcomes of a national screening program.

Authors:  James M Trauer; Bridget Williams; Ingrid Laemmle-Ruff; Danielle Horyniak; Lila V Soares Caplice; Emma S McBryde; Suman S Majumdar; Stephen M Graham; Margaret E Hellard
Journal:  Lancet Reg Health West Pac       Date:  2021-03-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.